So far, some meta-analyses have studied the effect of ki67 on the prognostic quality of life of patients with oesophageal cancer, breast cancer, epithelial ovarian cancer and so on.37–39 Some studies have also focused on other aspects of bladder cancer. This evidence concerns the gene MKI67 and urinary bladder cancer.